This hypermutator phenotype was also found associated to the promoter methylation of O [6]-methylguanine-DNA methyltransferase (MGMT), which removes alkyl residues from guanine residues in the DNA [47] and predicts GBM response to TMZ [48,49]. The gene discussed is MGMT; the disease is glioblastoma.